Edition:
United Kingdom

Arsanis Inc (ASNS.OQ)

ASNS.OQ on NASDAQ Stock Exchange Global Market

16.91USD
19 Jun 2018
Change (% chg)

$0.31 (+1.87%)
Prev Close
$16.60
Open
$16.46
Day's High
$16.96
Day's Low
$16.46
Volume
17,663
Avg. Vol
12,802
52-wk High
$27.83
52-wk Low
$10.50

Latest Key Developments (Source: Significant Developments)

Arsanis Posts Qtrly Loss Per Share $0.74
Thursday, 10 May 2018 

May 10 (Reuters) - Arsanis Inc ::ASN100 PHASE 2 TRIAL INTERIM ANALYSIS RESULTS EXPECTED IN LATE JUNE.QTRLY LOSS PER SHARE $0.74.AS OF MARCH 31, 2018, OUR CASH AND CASH EQUIVALENTS TOTALED $64.0 MILLION.  Full Article

Arsanis Inc - Out Licenses Preclinical Stage E. Coli Monoclonal Antibodies
Wednesday, 4 Apr 2018 

April 4 (Reuters) - Arsanis Inc ::LICENSES PRECLINICAL STAGE E. COLI MONOCLONAL ANTIBODIES.BB100 SECURED EXCLUSIVE,WORLDWIDE PRECLINICAL DEVELOPMENT LICENSE, OPTION TO DEVELOPMENT, COMMERCIALIZATION LICENSE, TO MABS TARGETING E. COLI.  Full Article

Arsanis Reports Q4 Net Loss $1.68 Per Share
Friday, 9 Mar 2018 

March 9 (Reuters) - Arsanis Inc ::ARSANIS REPORTS FINANCIAL RESULTS AND HIGHLIGHTS FOR FOURTH QUARTER AND FULL YEAR 2017.ARSANIS INC - FOR THE FOURTH QUARTER ENDED DECEMBER 31, 2017, ARSANIS REPORTED NET LOSS OF $1.68 LOSS PER SHARE.ARSANIS INC - AS OF DECEMBER 31, 2017, ARSANIS'S CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES AND INVESTMENTS TOTALED $76.8 MILLION.  Full Article

Arsanis Inc Files To Say It Has Raised $20 Million In Equity Financing - SEC Filing
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Arsanis Inc ::ARSANIS INC FILES TO SAY IT HAS RAISED $20 MILLION IN EQUITY FINANCING - SEC FILING.  Full Article

OrbiMed Advisors Reports 13.07 Percent Stake In Arsanis As Of Nov 20 - SEC Filing ‍​
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - OrbiMed Advisors LLC::ORBIMED ADVISORS LLC REPORTS 13.07 PERCENT STAKE IN ARSANIS INC AS OF NOVEMBER 20 - SEC FILING ‍​.ORBIMED ADVISORS LLC - CAUSED OPI IV TO ACQUIRE COMMON STOCK OF THE ARSANIS INC FOR THE PURPOSE OF MAKING AN INVESTMENT.  Full Article

Terrance G. Mcguire Reports A 13.7 Percent Stake In Arsanis Inc As Of November 20, 2017 - SEC Filig
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - Arsanis Inc ::TERRANCE G. MCGUIRE REPORTS A 13.7 PERCENT STAKE IN ARSANIS INC AS OF NOVEMBER 20, 2017 - SEC FILIG.  Full Article

New Enterprise Associates 16 L.P. Reports 14.6 Percent Stake In Arsanis As Of Nov 20
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - NEW ENTERPRISE ASSOCIATES 16 L.P:NEW ENTERPRISE ASSOCIATES 16 L.P. REPORTS A 14.6 PERCENT STAKE IN ARSANIS AS OF NOVEMBER 20, 2017 - SEC FILING.  Full Article

Arsanis Inc shares debut about 30 pct above IPO price‍​
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - :Arsanis Inc shares open at $13.00 in debut on the NASDAQ versus IPO price of $10.00 per share‍​.  Full Article

Arsanis prices initial public offering of 4 mln common shares at $10 per share​
Thursday, 16 Nov 2017 

Nov 15 (Reuters) - Arsanis Inc -:Arsanis announces pricing of initial public offering.‍Announced pricing of initial public offering of 4,000,000 shares of common stock at public offering price of $10.00 per share​.  Full Article

Arsanis Inc now sees IPO of 4 mln shares of common stock
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Arsanis Inc :Arsanis Inc now sees IPO of 4.0 million shares of common stock - sec filing‍​.Arsanis Inc says estimated initial public offering price is $10.00 per share.Arsanis Inc says had previously expected IPO of up to 3.13 million shares of common stock to be priced between $15 and $17 per share.Arsanis says intends to use about $34 million of IPO proceeds to fund development of asn100 for prevention of S. Aureus Pneumonia.  Full Article

BRIEF-Arsanis Posts Qtrly Loss Per Share $0.74

* ASN100 PHASE 2 TRIAL INTERIM ANALYSIS RESULTS EXPECTED IN LATE JUNE